Key facts
- Notable investors include Fujen Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Dianliang Napu
- ·The full record, as it builds
Funding rounds
No funding rounds for Dianliang Napu are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dianliang Napu
Provider of biomedical technologies services intended for research, diagnostics, and healthcare product distribution. The company offers services for molecular diagnostics, biobased material development, technical consulting, and instrument repair and sales, enabling life sciences and medical markets to access integrated solutions for experimental development, product innovation, and operational support across clinical and industrial applications
- Sector
- Healthcare
- HQ
- Kunshan, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Dianliang Napu doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dianliang Napu shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dianliang Napu in its N-PORT filings yet. We sweep new filings monthly.